跳转至内容
Merck
CN

1.24069

碳酸钙

EMPROVE® ESSENTIAL, Ph. Eur., BP, USP, E170, FCC

别名:

Calcium carbonate

登录 查看组织和合同定价。

选择尺寸


关于此项目

线性分子式:
CaCO3
化学文摘社编号:
分子量:
100.09
UNSPSC Code:
12352302
EC Index Number:
207-439-9
E Number:
E170
MDL number:
Beilstein/REAXYS Number:
8008338
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

碳酸钙, EMPROVE® ESSENTIAL, Ph. Eur., BP, USP, E170, FCC

InChI

1S/CH2O3.Ca/c2-1(3)4;/h(H2,2,3,4);/q;+2/p-2

SMILES string

[Ca++].[O-]C([O-])=O

InChI key

VTYYLEPIZMXCLO-UHFFFAOYSA-L

grade

GMO free
Halal
Kosher
cGMP

agency

BP
Ph. Eur.
USP

reg. compliance

FCC

product line

EMPROVE® ESSENTIAL

form

powder

density

2.93 g/mL at 25 °C (lit.)

application(s)

pharmaceutical
solid formulation

foreign activity

Aflatoxin

storage temp.

2-30°C

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

Due to regulatory developments, there is an increasing interest in titanium dioxide-free solutions for the coloring of solid dosage forms. Parteck® TA - our titanium dioxide alternative - is a mineral and nature-identical pigment specifically developed for the use in tablet film coatings. It helps to achieve a level of covering and whiteness comparable to titanium dioxide film coatings without affecting your tablets’ performance. The enhanced opacity is ensured by its unique morphology and designed particle size distribution

Features and Benefits

  • A mineral, nature-identical pigment
  • Excellent compatibility with HPMC and PVA film coatings (including our PARTECK® COAT excipient)
  • High process efficiency due to lower viscosity of spraying liquids
  • Enables an appealing and uniform tablet appearance
  • Enhanced opacity due to tailored particle size distribution and unique morphology

General description

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

存储类别

13 - Non Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

相关内容

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持